Suspicious urine cytology (class III) in patients with bladder cancer: Should it be considered as negative or positive?

Scandinavian Journal of Urology and Nephrology

Volumn 36, Issue 3, 2002, Pages 213-217

  Raitanen, M P ^a,b   Aine, R A T ^a   Kaasinen, E S ^c   Liukkonen, T J O ^d   Kylmala T M ^a   Huhtala, H ^e   Tammela, T L J ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^c HYVINKÄÄ HOSPITAL   (Finland)

^d MIKKELI CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Bladder cancer; Cytology; Marker; Urine

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CELL CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; CYTOPATHOLOGY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAPANICOLAOU TEST; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TUMOR RECURRENCE; URINE CYTOLOGY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; URINE;

EID: 18444408380     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655902320131901     Document Type: Article

References (19)

1. Urine sediment smears: A diagnostic procedure in cancers of the urinary tract
2. Current status of urinary cytology in evaluation of bladder neoplasms
3. Accuracy of cytological diagnosis of cancer of the urinary tract
4. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer
5. Ta and T1 bladder cancer: Location, recurrence and progression
6. Prognostic parameters in superficial bladder cancer: An analysis on 315 cases
7. Comparison of bladder washings and urine cytology in the diagnosis of bladder cancer
8. Diagnostic value of cytology of voided urine
9. Human complement factor H related protein (BTA stat) test in monitoring of bladder cancer
10. Comparison of the BTA stat Test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer
11. Comparative evaluation of the BTA stat Test, NMP 22, and voided urine cytology in the detection of primary and recurrent bladder tumors
12. Exfoliative cytology in the diagnosis and follow-up of urothelial neoplasms
13. Urinary BTA-stat, BTA-trak and NMP 22 in surveillance after TUR of recurrent superficial transitional cell carcinoma of the bladder
14. Comparison of screening methods in the detection of bladder cancer
15. Exclusion criteria enhance the specificity and positive predictive value of NMP 22 and BTA stat
16. Sensitivity of human complement factor H related protein (the BTA stat Test) test and voided urine cytology in the diagnosis of bladder cancer
17. Noninvasive detection of bladder cancer with the BTA stat test